tradingkey.logo
搜索

Artivion Inc

AORT
添加自选
27.015USD
+0.915+3.51%
收盘 07-28 16:00美东报价延迟15分钟
1.31B总市值
105.28市盈率 TTM

关于 Artivion Inc 公司

Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.

Artivion Inc简介

公司代码AORT
公司名称Artivion Inc
上市日期Feb 12, 1993
CEOMackin (James Patrick)
员工数量1600
证券类型Ordinary Share
年结日Feb 12
公司地址1655 Roberts Boulevard N W
城市KENNESAW
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编30144
电话17704193355
网址https://artivion.com/
公司代码AORT
上市日期Feb 12, 1993
CEOMackin (James Patrick)

Artivion Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
203.01K
+7.32%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
167.55K
+10.84%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
157.64K
+4.81%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
157.47K
+4.81%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
137.42K
+5.51%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
134.82K
+4.40%
Mr. James W. Bullock
Mr. James W. Bullock
Independent Director
Independent Director
76.22K
+9.94%
Mr. Jeffrey H. (Jeff) Burbank
Mr. Jeffrey H. (Jeff) Burbank
Lead Independent Director
Lead Independent Director
61.37K
+12.34%
Mr. Andrew M. Green
Mr. Andrew M. Green
Vice President - Regulatory Affairs
Vice President - Regulatory Affairs
60.26K
+44.40%
Dr. Marshall S. Stanton, M.D.
Dr. Marshall S. Stanton, M.D.
Senior Vice President, Clinical Research and Chief Medical Officer
Senior Vice President, Clinical Research and Chief Medical Officer
39.13K
+34.61%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
203.01K
+7.32%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
167.55K
+10.84%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
157.64K
+4.81%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
157.47K
+4.81%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
137.42K
+5.51%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
134.82K
+4.40%

常见问题

Artivion Inc的前五大股东是谁?

Artivion Inc 的前五大股东如下:Mr. John E. Davis

有多少机构持有Artivion Inc(AORT)的股份?

截至2026Q1,共有449家机构持有Artivion Inc的股份,合计持有的股份价值约为45.29M,占公司总股份的93.40%。与2025Q4相比,机构持股有所增加,增幅为501666.00。

哪个业务部门对Artivion Inc的收入贡献最大?

在2026Q1,Aortic stent grafts业务部门对Artivion Inc的收入贡献最大,创收159.37M,占总收入的36.11%。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有